Review
Bioactive compounds from herbal medicines to manage dyslipidemia

https://doi.org/10.1016/j.biopha.2019.109338Get rights and content
Under a Creative Commons license
open access

Highlights

  • Lipid metabolism disorders are affecting a large population.

  • Bioactive compounds from herbal medicine possess Lipid lowering properties through four pathways of lipid metabolism, including inhibition of cholesterol absorption in enterocytes, reduction of cholesterol synthesis, elevation of reverse cholesterol transport, and promotion of cholesterol excretion in the liver.

  • Bioactive compounds from herbal medicine exert in lipid lowering activities by modulating various molecular targets and related pathways.

  • Bioactive compounds from herbal medicine are mostly safe and very well tolerated, however more work needs to be done in concerning the safety.

Abstract

Dyslipidemia is a key risk factor for cardiovascular diseases, which are a major cause of morbidity and mortality worldwide. However, despite the advancement of the treatment and prevention of dyslipidemia, medications used to treat dyslipidemia are limited to chemical drugs. Herbal medicine, as an alternative treatment, has a long history of usage and provides more treatment options, and related studies have revealed intervention targets for dyslipidemia. Four lipid-lowering mechanisms of herbal medicines have been proposed and are discussed in this paper. These mechanisms are the inhibition of cholesterol absorption in enterocytes, reduction of cholesterol synthesis, elevation of reverse cholesterol transport, and promotion of cholesterol excretion in the liver. This review elaborates on the underlying molecular pathways involved in plasma lipid balance via bioactive compounds from herbal medicines.

Abbreviations

TC
total cholesterol
LDL-C
low density lipoprotein cholesterol
TG
triglyceride
HDL-C
high density lipoprotein cholesterol
CE
cholesterol ester
FC
free cholesterol
ER
endoplasmic reticulum
NPC1L1
protein Niemann-Pick C1 like1
ACAT
acyl CoA cholesterol acyltransferase
MTTP
microsomal triglyceride transfer protein
SREBP
sterol regulatory element binding protein
LXR
liver X receptor
HMGCR
HMG-CoA reductase
SQS
squalene synthase
AMPK
AMP-activated protein kinase
RCT
reverse cholesterol transport
ABCA1
ATP-binding cassette transporter A1
ABCG1
ATP-binding cassette transporter G1
SR-A
scavenger receptor class A
LCAT
lecithin cholesterol acyltransferase
CETP
cholesterol ester transporter
oxLDL
oxidized low-density lipoprotein
LDLR
low-density lipoprotein receptor
PCSK9
proprotein convertase subtilisin/kexin type 9
CYP7A1
cholesterol 7-alpha hydroxylase
LPL
lipoprotein lipase
HL
hepatic lipase

Keywords

Dyslipidemia
Herbal medicine
Underlying mechanisms
Bioactive
Compounds

Cited by (0)

1

These authors contributed equally to this study.